Skip to main content

Advertisement

Log in

Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

This study sought to determine the minimal serum 25-hydroxyvitamin D [25(OH)D] concentration required to maintain bone health in postmenopausal women with low bone mass. A serum 25(OH)D concentration of 20 ng/mL rather than 30 ng/mL was appropriate for bone health.

Introduction

There is no consensus on the minimal serum 25-hydroxyvitamin D [25(OH)D] concentration required to maintain bone health. The aim of this study was to investigate the relationship between 25(OH)D measured via liquid chromatography-mass spectrometry (LC–MS/MS), which is the current gold standard, and biochemical markers of bone turnover, PTH, and bone mineral densitometry (BMD).

Methods

The medical records of 750 postmenopausal women newly diagnosed with osteoporosis or osteopenia at Samsung Medical Center from 2009 to 2014 were investigated. Subjects were divided into four groups according to serum 25(OH)D concentration: <10, 10–20, 20–30, and ≥30 ng/mL. Serum concentrations of bone-specific alkaline phosphatase (BS-ALP), carboxy-terminal cross-linking telopeptide of type 1 collagen (CTx), intact PTH (iPTH), and BMD were compared among the four groups using analysis of covariance. Thresholds of 25(OH)D were then assessed using spline plots and locally weighted regression smoothing (LOESS) plots.

Results

25(OH)D was negatively correlated with serum BS-ALP, CTx, and iPTH. Only femur neck and total femur BMD had significant positive relationships with 25(OH)D. Cutoff values of 11.9 and 9.7 ng/mL were estimated from the spline plots of femur neck and total femur BMD, respectively. For iPTH, the LOESS plot showed a steep decrease to a serum 25(OH)D concentration of about 20 ng/mL, followed by a plateau.

Conclusions

According to this study, a serum 25(OH)D concentration of 20 ng/mL, rather than 30 ng/mL, was appropriate for bone health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553

    Article  CAS  PubMed  Google Scholar 

  2. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477–501. doi:10.1210/edrv.22.4.0437

    Article  CAS  PubMed  Google Scholar 

  3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. doi:10.1210/jc.2011-0385

    Article  CAS  PubMed  Google Scholar 

  4. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154. doi:10.1007/s00198-010-1285-3

    Article  CAS  PubMed  Google Scholar 

  5. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, Rosen C, Guidelines Committee of the Scientific Advisory Council of Osteoporosis C (2010) Vitamin D in adult health and disease: a review and guideline statement from osteoporosis Canada. CMAJ 182(12):E610–E618. doi:10.1503/cmaj.080663

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58. doi:10.1210/jc.2010-2704

    Article  CAS  PubMed  Google Scholar 

  7. Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, Patel S, Selby P, Tanna N, Francis RM, National Osteoporosis S (2014) National Osteoporosis Society vitamin D guideline summary. Age Ageing 43(5):592–595. doi:10.1093/ageing/afu093

    Article  PubMed  Google Scholar 

  8. Rizzoli R, Boonen S, Brandi ML, Bruyere O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO). Curr Med Res Opin 29(4):305–313. doi:10.1185/03007995.2013.766162

    Article  CAS  PubMed  Google Scholar 

  9. (2003) Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921:1–164. back cover

  10. Su Z, Narla SN, Zhu Y (2014) 25-hydroxyvitamin D: analysis and clinical application. Clin Chim Acta 433:200–205. doi:10.1016/j.cca.2014.03.022

    Article  CAS  PubMed  Google Scholar 

  11. de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M (2010) UK Food Standards Agency workshop consensus report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and nutrition survey. Br J Nutr 104(4):612–619. doi:10.1017/S000711451000214X

    Article  PubMed  Google Scholar 

  12. Singh RJ, Taylor RL, Reddy GS, Grebe SK (2006) C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 91(8):3055–3061. doi:10.1210/jc.2006-0710

    Article  CAS  PubMed  Google Scholar 

  13. Carter GD, Jones JC (2009) Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 46(Pt 1):79–81. doi:10.1258/acb.2008.008135

    Article  CAS  PubMed  Google Scholar 

  14. Hui SL, Gao S, Zhou XH, Johnston CC Jr, Lu Y, Gluer CC, Grampp S, Genant H (1997) Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res 12(9):1463–1470. doi:10.1359/jbmr.1997.12.9.1463

    Article  CAS  PubMed  Google Scholar 

  15. Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward’s triangle. Osteoporos Int 12(6):438–444. doi:10.1007/s001980170087

    Article  CAS  PubMed  Google Scholar 

  16. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94(4):1244–1250. doi:10.1210/jc.2008-1832

    Article  PubMed  Google Scholar 

  17. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 24(4):693–701. doi:10.1359/jbmr.081209

    Article  CAS  PubMed  Google Scholar 

  18. Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, Fuleihan Gel H (2012) 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 97(3):835–843. doi:10.1210/jc.2011-2584

    Article  CAS  PubMed  Google Scholar 

  19. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M (2012) State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 58(3):531–542. doi:10.1373/clinchem.2011.172155

    Article  CAS  PubMed  Google Scholar 

  20. Lai JK, Lucas RM, Banks E, Ponsonby AL (2012) Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 42(1):43–50. doi:10.1111/j.1445-5994.2011.02471.x

    Article  CAS  PubMed  Google Scholar 

  21. Binkley N, Wiebe D (2013) Clinical controversies in vitamin D: 25(OH)D measurement, target concentration, and supplementation. J Clin Densitom 16(4):402–408. doi:10.1016/j.jocd.2013.08.006

    Article  PubMed  Google Scholar 

  22. Wallace AM, Gibson S, de la Hunty A, Lamberg-Allardt C, Ashwell M (2010) Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 75(7):477–488. doi:10.1016/j.steroids.2010.02.012

    Article  CAS  PubMed  Google Scholar 

  23. Fraser WD, Milan AM (2013) Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 92(2):118–127. doi:10.1007/s00223-012-9693-3

    Article  CAS  PubMed  Google Scholar 

  24. Granado-Lorencio F, Mosteiro JS, Herrero-Barbudo C, Navarro ED, Blanco-Navarro I, Perez-Sacristan B (2010) 25-OH-vitamin D assay variation and subject management in clinical practice. Clin Biochem 43(4–5):531–533. doi:10.1016/j.clinbiochem.2009.11.020

    Article  CAS  PubMed  Google Scholar 

  25. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF, Drezner MK (2004) Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89(7):3152–3157. doi:10.1210/jc.2003-031979

    Article  CAS  PubMed  Google Scholar 

  26. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stahelin HB, Theiler R, Dawson-Hughes B (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367(1):40–49. doi:10.1056/NEJMoa1109617

    Article  CAS  PubMed  Google Scholar 

  27. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7(5):439–443

    Article  CAS  PubMed  Google Scholar 

  28. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169(6):551–561. doi:10.1001/archinternmed.2008.600

    Article  CAS  PubMed  Google Scholar 

  29. Sai AJ, Walters RW, Fang X, Gallagher JC (2011) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96(3):E436–E446. doi:10.1210/jc.2010-1886

    Article  CAS  PubMed  Google Scholar 

  30. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, Amling M (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25(2):305–312. doi:10.1359/jbmr.090728

    Article  CAS  PubMed  Google Scholar 

  31. Heaney RP, Dowell MS, Hale CA, Bendich A (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22(2):142–146

    Article  CAS  PubMed  Google Scholar 

  32. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18):2257–2264. doi:10.1001/jama.293.18.2257

    Article  CAS  PubMed  Google Scholar 

  33. Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, Marvdashti S (2015) Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial. JAMA Intern Med 175(10):1612–1621. doi:10.1001/jamainternmed.2015.3874

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A (2016) Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 176(2):175–183. doi:10.1001/jamainternmed.2015.7148

    Article  PubMed  Google Scholar 

  35. Fan B, Lu Y, Genant H, Fuerst T, Shepherd J (2010) Does standardized BMD still remove differences between Hologic and GE-lunar state-of-the-art DXA systems? Osteoporos Int 21(7):1227–1236. doi:10.1007/s00198-009-1062-3

    Article  CAS  PubMed  Google Scholar 

  36. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4(3):283–291. doi:10.1002/jbmr.5650040302

    Article  CAS  PubMed  Google Scholar 

  37. Suzuki Y, Whiting SJ, Davison KS, Chilibeck PD (2003) Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen. J Nutr Health Aging 7(5):296–299

    CAS  PubMed  Google Scholar 

  38. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80(4):1052–1058. doi:10.1210/jcem.80.4.7714065

    CAS  PubMed  Google Scholar 

  39. Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, van Kuijk C, Schutte HE, Birkenhager JC, Pols HA (1994) The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam study. Bone Miner 25(1):1–13

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Yaeji Lim and Kiyoun Kim of the Biostatistics and Clinical Epidemiology Center, Samsung Medical Center for statistical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y.-K. Min.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, D.Y., Jee, J.H., Cho, Y.Y. et al. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis. Osteoporos Int 28, 1377–1384 (2017). https://doi.org/10.1007/s00198-016-3892-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3892-0

Keywords

Navigation